Skip to Content

SEC Filing

Document Details

Form
Filing Date
Feb 23, 2023
Document Date
Feb 17, 2023
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Kinnate Biopharma
Issuer
Kinnate Biopharma Inc.
Filer
ORBIMED CAPITAL GP VIII LLC